Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Immune Reconstitution Following Infusion of Autologous Blinatumomab Expanded T-Cells (BET) in CD20+ Indolent Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia Receiving Front-Line Treatment with Fludarabine-Cyclophosphamide-Rituximab or Bendamustine-Rituximab

Giuseppe Gritti, Federico Lussana, Silvia Ferrari, Anna Maria Barbui, Francesco Landi, Giulia Quaresmini, Gianmaria Borleri, Muriel Paganessi, Chiara Pavoni, Elisa Gotti, Chiara Capelli, Josee Golay, Martino Introna, Alessandro Rambaldi

Blood (2022) 140 (Supplement 1): 10325–10326.

https://doi.org/10.1182/blood-2022-170120

Published: 2022

Journal Articles

Massive, Clinical Grade Expansion Of Polyclonal T Cells Using Blinatumomab For Adoptive Autologous Cellular Therapy Of CLL Patients

Josée Golay, PhD, Anna D’amico, PhD, Gianmaria Borleri, Maria Chiara Finazzi, MD, Giulia Quaresmini, MD, Martino Introna, MD, Alessandro Rambaldi, MD

Blood (2013) 122 (21): 3272.

https://doi.org/10.1182/blood.V122.21.3272.3272

Published: 2013

Journal Articles

A Phase II Study of Sequential Administration of DLI and Cytokine Induced Killer (CIK) Cells in Patients with Hematologic Malignancies Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation: Preliminary Results

Martino Introna, MD, Alessandra Algarotti, MD, Caterina Micò, MD, Anna Grassi, MD, Alice Pievani, PhD, Gianmaria Borleri, Josée Golay, PhD, Irene Cavattoni, MD, Sergio Cortelazzo, MD, Alessandro Rambaldi

Blood (2011) 118 (21): 657.

https://doi.org/10.1182/blood.V118.21.657.657

Published: 2011

Journal Articles

Dual-functional capability of CD3 + CD56 + CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity

Alice Pievani, Gianmaria Borleri, Daniela Pende, Lorenzo Moretta, Alessandro Rambaldi, Josée Golay, Martino Introna

Blood (2011) 118 (12): 3301–3310.

https://doi.org/10.1182/blood-2011-02-336321

Published: 2011

Includes: Supplemental data

Journal Articles

Cytokine Induced Killer Cells Can Kill Target through Antigen/TCR Dependent and Independent Mechanisms: New Clinical Perspectives of Utilisation.

Alice Pievani, Gianmaria Borleri, Camilla Belussi, Alessandro Rambaldi, Josee Golay, Martino Introna, MD

Blood (2009) 114 (22): 3024.

https://doi.org/10.1182/blood.V114.22.3024.3024

Published: 2009

Journal Articles

Infusion of Donor Derived Cytokine Induced Killer Cells May Induce Clinical Remission with Limited GVHD in Patients Relapsing after Allogeneic Stem Cell Transplantation.

Martino Introna, MD, Gianmaria Borleri, Elena Conti, Anna M. Barbui, MD, Raewyn Broady, BSc, Erica Dander, BSc, Giuseppe Gaipa, BSc, Giovanna D’Amico, BSc, Ettore Biagi, MD, Matteo Parma, MD, Enrico Pogliani, MD, Orietta Spinelli, BSc, Donatella Baronciani, MD, Anna Grassi, MD, Josee Golay, PhD, Tiziano Barbui, MD, Andrea Biondi, MD, Alessandro Rambaldi, MD

Blood (2006) 108 (11): 3698.

https://doi.org/10.1182/blood.V108.11.3698.3698

Published: 2006

Journal Articles

Rapid and Massive Expansion of Cord Blood Derived Cytokine Induced Killer (CIK) Cells: An Innovative Proposal for the Treatment of Leukemia Relapse after Cord Blood Transplantation.

Martino Introna, MD, Marta Franceschetti, BSc, Alice Ciocca, BSc, Gianmaria Borleri, Elena Conti, Josee Golay, PhD, Alessandro Rambaldi, MD

Blood (2006) 108 (11): 723.

https://doi.org/10.1182/blood.V108.11.723.723

Published: 2006

Journal Articles

CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59

Josée Golay, Manuela Lazzari, Valeria Facchinetti, Sergio Bernasconi, Gianmaria Borleri, Tiziano Barbui, Alessandro Rambaldi, Martino Introna

Blood (2001) 98 (12): 3383–3389.

https://doi.org/10.1182/blood.V98.12.3383

Published: 2001

Journal Articles

Innovative Two-Step Negative Selection of Granulocyte Colony-Stimulating Factor–Mobilized Circulating Progenitor Cells: Adequacy for Autologous and Allogeneic Transplantation

Alessandro Rambaldi, Gianmaria Borleri, Gianpietro Dotti, Piermario Bellavita, Ricardo Amaru, Andrea Biondi, Tiziano Barbui

Blood (1998) 91 (6): 2189–2196.

https://doi.org/10.1182/blood.V91.6.2189

Published: 1998

NARROW

Immune Reconstitution Following Infusion of Autologous Blinatumomab Expanded T-Cells (BET) in CD20+ Indolent Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia Receiving Front-Line Treatment with Fludarabine-Cyclophosphamide-Rituximab or Bendamustine-Rituximab

Massive, Clinical Grade Expansion Of Polyclonal T Cells Using Blinatumomab For Adoptive Autologous Cellular Therapy Of CLL Patients

A Phase II Study of Sequential Administration of DLI and Cytokine Induced Killer (CIK) Cells in Patients with Hematologic Malignancies Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation: Preliminary Results

Dual-functional capability of CD3 + CD56 + CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity

Cytokine Induced Killer Cells Can Kill Target through Antigen/TCR Dependent and Independent Mechanisms: New Clinical Perspectives of Utilisation.

Infusion of Donor Derived Cytokine Induced Killer Cells May Induce Clinical Remission with Limited GVHD in Patients Relapsing after Allogeneic Stem Cell Transplantation.

Rapid and Massive Expansion of Cord Blood Derived Cytokine Induced Killer (CIK) Cells: An Innovative Proposal for the Treatment of Leukemia Relapse after Cord Blood Transplantation.

CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59

Innovative Two-Step Negative Selection of Granulocyte Colony-Stimulating Factor–Mobilized Circulating Progenitor Cells: Adequacy for Autologous and Allogeneic Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only